Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Similar
Filing Names

Csl Limited
Csl Limited_20100114
  

Csl Limited patents

Recent patent applications related to Csl Limited. Csl Limited is listed as an Agent/Assignee. Note: Csl Limited may have other listings under different names/spellings. We're not affiliated with Csl Limited, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "C" | Csl Limited-related inventors




Date Csl Limited patents (updated weekly) - BOOKMARK this page
09/07/17Factor viii formulation
08/10/17Antibodies against g-csfr and uses thereof
07/13/17Reconstituted high density lipoprotein formulation and production method thereof
06/01/17Modified von willebrand factor
05/11/17Production of recombinant von willebrand factor in a bioreactor
02/16/17Half-life extended factor fviia protein for prevention and treatment of bleeding and dosing regimens therefor
02/09/17Method of treating nephropathy
02/02/17Method of inhibition of leukemic stem cells
01/19/17Anti-tumor compositions and uses thereof
12/29/16Method of treating cancer
12/22/16Method for improving the stability of purified factor viii after reconstitution
12/15/16High affinity antibody antagonists of interleukin-13 receptor alpha 1
12/01/16Fusion proteins comprising factor ix for prophylactic treatment of hemophilia and methods thereof
11/03/16Method of treating wounds
10/20/16Method of treatment of philadelphia chromosome positive leukemia
10/06/16New method to concentrate von willebrand factor or complexes thereof
07/14/16Complex
06/30/16Method of purifying polypeptides
06/23/16Dosage regime for apolipoprotein formulations
06/23/16Process for preparing apolipoprotein a-i (apo a-i)
06/23/16Contaminant removal method
02/18/16Agents that neutralize il-3 signalling and uses thereof
02/04/16Anti il-3r alpha agents and uses thereof
02/04/16Antibodies against g-csfr and uses thereof
02/04/16Il-11r binding proteins
01/28/16Reconstituted high density lipoprotein formulation and production method thereof
01/28/16Purification of vwf
01/07/16In vivo efficacy of ny-eso-1 plus adjuvant
12/24/15A purifying therapeutic proteins
10/29/15Reconstituted hdl formulation
10/29/15Humanized anti-interleukin 3 receptor alpha chain antibodies
06/11/15Method of purifying therapeutic proteins
06/04/15Method of inhibition of leukemic stem cells
05/28/15Compositions and methods for targeting type 1 interferon producing cells
04/02/15Method of treatment of philadelphia chromosome positive leukemia
02/05/15Anti-tumor compositions and uses thereof
01/15/15Treatment of chronic inflammatory conditions
12/25/14Dosage regime for apolipoprotein formulations
10/09/14Porphyromonas gingivalis polypeptides and nucleotides
09/04/14Method for improving the stability of purified factor viii after reconstitution
08/21/14Treatment of neurological conditions
08/07/14Il-11r binding proteins and uses thereof
06/26/14Compositions and methods for targeting type 1 interferon producing cells
06/05/14Method of purifying therapeutic proteins
03/27/14Humanized anti-interleukin 3 receptor alpha chain antibodies
03/20/14Methods of purifying polypeptides
02/27/14Treatment of pulmonary disease conditions
02/27/14High affinity antibody antagonists of interleukin-13 receptor alpha 1
01/30/14Method of cloning nucleic acid
01/30/14Method for polishing albumin
11/14/13Method of treatment
09/05/13Method of inhibition of leukemic stem cells
07/25/13Reconstituted high density lipoprotein formulation and production method thereof
06/27/13Method of treating inflammatory bowel disease
06/13/13Immunotherapeutic method involving cd123 (il-3ra) antibodies and immunostimulating complex
06/13/13Porphyromonas gingivalis polypeptides and nucleotides
05/30/13Humanized anti-interleukin 3 receptor alpha chain antibodies
04/04/13Compositions and methods for targeting type 1 interferon producing cells
12/20/12Antibodies against g-csfr and uses thereof
12/20/12Methods of increasing the expression yield of vitamin k-dependent proteins
09/27/12Method of treatment of philadelphia chromosome positive leukaemia
07/05/12In vivo efficacy of ny-eso-1 plus adjuvant
12/08/11Il-11 muteins
08/04/11Treatment of endothelial dysfunction in diabetic patients
05/12/11Treatment of uveitis
Patent Packs
04/21/11Treatment of neurological conditions
03/17/11Compositions comprising immunoreactive reagents and saponins, and methods of use thereof
11/18/10Method of eliciting an immune response against pandemic influenza virus
10/21/10Therapeutic antibody purification method and use
07/22/10Method of treatment
01/14/10Immunogenic complexes and methods relating thereto
12/31/09Treatment of pulmonary disease conditions
10/08/09Papilloma virus vaccine
07/30/09Cytokine muteins
01/14/10Immunogenic complexes and methods relating thereto







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Csl Limited in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Csl Limited with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';